Symrise AG Retained Earnings (Accumulated Deficit) 2018-2024 | SYIEY
Symrise AG retained earnings (accumulated deficit) from 2018 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Symrise AG retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $1.711B, a 12.44% increase year-over-year.
- Symrise AG retained earnings (accumulated deficit) for 2023 were $1.711B, a 16.98% increase from 2022.
- Symrise AG retained earnings (accumulated deficit) for 2022 were $1.463B, a 3.88% decline from 2021.
- Symrise AG retained earnings (accumulated deficit) for 2021 were $1.522B, a 27.09% increase from 2020.
Symrise AG Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$1,711 |
| 2022 |
$1,463 |
| 2021 |
$1,522 |
| 2020 |
$1,197 |
| 2019 |
$988 |
| 2018 |
$833 |
| 2017 |
$641 |
| 2016 |
$ |
Symrise AG Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023-12-31 |
$1,711 |
| 2023-06-30 |
$1,557 |
| 2022-12-31 |
$1,463 |
| 2022-06-30 |
$1,432 |
| 2021-12-31 |
$1,522 |
| 2021-06-30 |
$1,336 |
| 2020-12-31 |
$1,197 |
| 2020-06-30 |
$1,006 |
| 2019-12-31 |
$988 |
| 2019-06-30 |
$820 |
| 2018-12-31 |
$833 |
| 2018-06-30 |
$692 |
| 2017-12-31 |
$641 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Cosmetics and Toiletries |
$15.425B |
$5.134B |
|
Symrise AG manufactures, develops and sells fragrances, flavorings, cosmetic base materials and substances for the cosmetics industry. The company's operating segments consists of Scent & Care and Flavor & Nutrition. Scent and Care segment develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances. Flavor and Nutrition segment develops, produces and sells flavors which are used by customers in the production of food products and beverages. Its product includes perfume, cosmetics and food manufacturers to pharmaceutical companies and producers of nutritional supplements, pet food and baby food. The company operates primarily in Europe, Africa, the Middle East, North America, the Asia Pacific and Latin America. Symrise AG is headquartered in Holzminden, Germany.
|
